Edition:
United States

People: Celldex Therapeutics Inc (CLDX.A)

CLDX.A on American Stock Exchange

2.21USD
10 Jul 2019
Change (% chg)

-- (--)
Prev Close
$2.21
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
348
52-wk High
$9.00
52-wk Low
$2.41

Martin, Sam 

Mr. Sam Martin is Chief Financial Officer, Senior Vice President, Secretary of the Company effective July 1, 2017. Mr. Martin joined Celldex in April 2009 and currently serves as Vice President, Finance. Mr. Martin joined Celldex as the Director of Financial Reporting, Planning and Analysis in April 2009 and has held roles of increasing responsibility and leadership. Prior to joining Celldex, Mr. Martin served as the Director of Finance and Corporate Compliance for Alseres Pharmaceuticals, Inc., where he was responsible for managing the financial and SEC reporting and the annual budget and planning process. Mr. Martin began his career at Ernst & Young LLP, holding various positions prior to completing his tenure as Audit Manager, where he provided audit, review, due diligence and consulting services to public and private companies in the biotechnology, medical device, health care, high technology, manufacturing and consumer product industries. Mr. Martin received an M.B.A. from Boston University, a B.S. from Skidmore College and is a Certified Public Accountant.

Basic Compensation

Total Annual Compensation, USD 442,615
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 179,631
Fiscal Year Total, USD 622,246

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Larry Ellberger

127,469

Anthony Marucci

1,385,350

Sam Martin

622,246

Tibor Keler

748,713

Sarah Cavanaugh

--

Elizabeth Crowley

585,708
As Of  30 Dec 2018